InsidersTradesSigma
Follow the Hangzhou Tigermed Consulting Co., Ltd. - H Shares stock price and the full insider trade history of the company, a listed issuer based in Hong Kong. Shares trade on the HK market, under the authority of HKEX. Market capitalisation: €46.8bn. The latest transaction was disclosed on 19 May 2026 (Other). Among the most active insiders: Cao xiaochun. Every trade is free.
Analysts rate Hangzhou Tigermed Consulting Co., Ltd. - H Shares Buy (bullish), based on 13 analysts. Average price target: CN¥62.28.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
杭州泰格医药科技股份有限公司是一家专注于临床研究服务的中国公司。它致力于支持制药和生物制药公司开发新药。